| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alpha-adrenoceptor inhibitors in the treatment of benign prostatic hyperplasia
|
Kirby, Roger S.
|
|
1989
|
87 |
2S1 |
p. S26-S30
5 p.
|
artikel
|
| 2 |
Clinical Pharmacotherapeutics of Doxazosin
|
Taylor, Stanley H.
|
|
1989
|
87 |
2S1 |
p. S2-S11
10 p.
|
artikel
|
| 3 |
Closing remarks
|
Taylor, Stanley H.
|
|
1989
|
87 |
2S1 |
p. S66-
1 p.
|
artikel
|
| 4 |
Controlling drug effects through improved oral formulations
|
DiPiro, Joseph T.
|
|
1989
|
87 |
2S1 |
p. S31-S35
5 p.
|
artikel
|
| 5 |
Efficacy and safety of Minipress XL, a new once-a-day formulation of prazosin
|
Singleton, Walter
|
|
1989
|
87 |
2S1 |
p. S45-S52
8 p.
|
artikel
|
| 6 |
Introduction
|
Taylor, Stanley H.
|
|
1989
|
87 |
2S1 |
p. S1-
1 p.
|
artikel
|
| 7 |
Management of hypertension
|
Grimm Jr., Richard H.
|
|
1989
|
87 |
2S1 |
p. S62-S65
4 p.
|
artikel
|
| 8 |
Mechanisms contributing to the arrhythmogenic influences of Alpha1-adrenergic stimulation in the ischemic heart
|
Corr, Peter B.
|
|
1989
|
87 |
2S1 |
p. S19-S25
7 p.
|
artikel
|
| 9 |
Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension
|
Davey, Michael J.
|
|
1989
|
87 |
2S1 |
p. S36-S44
9 p.
|
artikel
|
| 10 |
Publisher's note
|
|
|
1989
|
87 |
2S1 |
p. iii-
1 p.
|
artikel
|
| 11 |
Review of the effects of doxazosin, a new selective alpha1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension
|
Pool, James L.
|
|
1989
|
87 |
2S1 |
p. S57-S61
5 p.
|
artikel
|
| 12 |
Selective alpha1-adrenergic blockade, lipids, and coronary heart disease risk
|
Graham, Robert M.
|
|
1989
|
87 |
2S1 |
p. S53-S56
4 p.
|
artikel
|
| 13 |
Structure and Function of Alpha-Adrenergic Receptors
|
Insel, Paul A.
|
|
1989
|
87 |
2S1 |
p. S12-S18
7 p.
|
artikel
|
Tijdschrift beschrijving